Study finds almost 1 in 3 large clinical trials still not published 5 years after completion
Almost one in three (29%) large clinical trials remain unpublished five years after completion. And of these, 78% have no results publicly available, finds a study published on bmj.com today.
This means that an estimated 250,000 people have been exposed to the risks of trial participation without the societal benefits that accompany the dissemination of their results, say the authors.
They argue that this “violates an ethical obligation that investigators have towards study participants” and call for additional safeguards “to ensure timely public dissemination of trial data.”
Randomized clinical trials are a critical means of advancing medical knowledge. They depend on the willingness of people to expose themselves to risks, but the ethical justification for these risks is that society will eventually benefit from the knowledge gained from the trial.
But when trial data remain unpublished, the societal benefit that may have motivated someone to enrol in a study remains unrealized.
US law requires that many trials involving human participants be registered – and their results posted – on the largest clinical trial website ClinicalTrials.gov. But evidence suggests that this legislation has been largely ignored.
So a team of US-based researchers set out to estimate the frequency of non-publication of trial results and, among unpublished studies, the frequency with which results are unavailable in the ClinicalTrials.gov database.
They searched scientific literature databases and identified 585 trials with at least 500 participants that were registered with ClinicalTrials.gov and completed prior to January 2009. The average time between study completion and the final literature search (November 2012) was 60 months for unpublished trials.
Registry entries for unpublished trials were then reviewed to determine whether results for these studies were available in the ClinicalTrials.gov results database.
Of 585 registered trials, 171 (29%) remained unpublished. Of these, 133 (78%) had no results available in ClinicalTrials.gov. Non-publication was more common among trials that received industry funding (32%) than those that did not (18%).
“Our results add to existing work by showing that non-publication is an important problem even among large randomized trials,” say the authors. Furthermore, the sponsors and investigators of these unpublished trials infrequently utilize the ClinicalTrials.gov results database.
Go deeper with Bing News on:
- PRA Health Sciences appoints senior FDA official to lead new Global Center of Excellence for Decentralized Clinical Trial Strategyon November 19, 2020 at 1:19 pm
(GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today the appointment of Isaac Rodriguez-Chavez, PhD, MHS, MS, as Senior Vice President, Scientific and Clinical Affairs. He will ...
- Clare Wallis Joins Worldwide Clinical Trials as Senior Vice President, Oncologyon November 19, 2020 at 10:05 am
Worldwide Clinical Trials, Inc. (Worldwide), a full-service, midsize, global contract research organization (CRO), announced today that Clare Wallis h ...
- UW researchers participate in clinical trial for new treatment to combat neuroblastomaon November 19, 2020 at 9:45 am
The new trial, which is being conducted by University of Wisconsin School of Medicine and Public Health researchers, is investigating a combination of radiation therapy and immunotherapy to treat the ...
- Medable Secures $91 Million Funding to Accelerate Industry Shift to Digital and Decentralized Clinical Trialson November 19, 2020 at 8:43 am
Medable today announced $91 million in new funding to accelerate the life sciences industry’s shift to digital and decentralized clinical trials.
- Ocuphire Pharma Announces First Patient Enrolled in MIRA-2 Phase 3 Clinical Trial Investigating Nyxol® for Reversal of Mydriasison November 19, 2020 at 4:29 am
Stage Trials in the U.S. Announces MIRA-1 Phase 2b Study Accepted for Peer-Reviewed Publication in Optometry and Vision Scienc ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Unpublished trial data
- Scientists hail ‘amazing result’ as study shows Roche arthritis drug Actemra helps sickest Covid-19 patients improveon November 19, 2020 at 9:49 am
A rheumatoid arthritis drug helped the sickest Covid-19 patients improve in a trial of 303 people, scientists said on Thursday, boosting hopes that it may be possible to effectively tackle the virus ...
- Arthritis drug ‘effective in treating critically ill Covid-19 patients’on November 19, 2020 at 6:54 am
A drug used to treat rheumatoid arthritis can improve clinical outcomes of critically ill patients with Covid-19, early results suggest. Tocilizumab, a medicine that suppresses the immune system and ...
- The Geek in Pictures: Post-Election Editionon November 11, 2020 at 4:00 pm
These data are proprietary and unpublished (and not based on exit polls, but on large samples cultivated over several years, plus a close look at actual election results on a state-by-state level ...
- COVID-19 Vaccine Answers Start to Arrive, But Americans Still Have Concernson November 10, 2020 at 5:41 pm
Meantime, Pfizer Monday announced that early, unpublished data indicated that its COVID ... about a vaccine or being involved in a vaccine trial. And people are far more wary about a coronavirus ...
- NIH Panel: More Data Needed to Determine Effectiveness of Convalescent Plasma for Covid-19on November 10, 2020 at 4:00 pm
To come to this determination, the COVID-19 Treatment Guidelines Panel said it reviewed the available evidence from published and unpublished data on convalescent plasma ... patients with COVID-19 and ...